News & Media

Explore our press releases, fact sheets, and other resources to find the latest news and information about Baxter. Also, follow us on our corporate social media channels.

Press Releases

Filter by:

Jun 23, 2016

New Baxter Study Demonstrates Perceived Value of Telemedicine to Increase Access to Care and Reduce Hospitalizations

Jun 16, 2016

Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate Within the First Month of Implementation

May 24, 2016

Baxter Announces Final Results of Baxalta Exchange Offer

May 24, 2016

Baxter Unveils Innovative THERANOVA Dialyser at 2016 ERA-EDTA Congress

May 23, 2016

Baxter Presents Data Focused on Elevating the Quality of Care for Renal Patients

May 19, 2016

Baxter Announces Preliminary Results of Baxalta Exchange Offer

May 18, 2016

Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments

May 18, 2016

"Health Affairs" Founding Editor, John K. Iglehart, Named 2016 Recipient of the William B. Graham Prize for Health Services Research

May 17, 2016

Baxter to Present at the 2016 Goldman Sachs Conference

May 17, 2016

Baxter Announces Final Exchange Ratio of 1.1591 for Baxalta Exchange Offer

May 10, 2016

Baxter to Present at the 2016 UBS Global Healthcare Conference

May 9, 2016

Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference

May 5, 2016

Baxter Announces Appointment of Interim President for Its Renal Business

May 4, 2016

Baxter Increases the Size of Its Previously Announced Offer to Exchange Shares of Baxter for Shares of Baxalta

May 3, 2016

Baxter Raises Quarterly Dividend

Apr 26, 2016

Baxter Reports First Quarter 2016 Results and Provides Updated Financial Outlook for Full-Year 2016

Apr 21, 2016

Baxter Initiates Offer to Exchange Shares of Baxter for Shares of Baxalta

Apr 20, 2016

Baxter Receives Marketing Authorization in the United Kingdom and Denmark for NUMETA G13E Ready-To-Use IV Nutrition for Preterm Newborns

Apr 19, 2016

Baxter Announces U.S. Launch of Premix Drug VANCOMYCIN Injection in Sodium Chloride

Apr 18, 2016

Baxter to Present at the 2016 Bank of America Healthcare Conference

Apr 14, 2016

Baxter-Supported Community Partnership in India Launches Mobile Health Application to Expand Healthcare for Women and Children

Apr 5, 2016

Baxter International Inc. to Host 2016 Investor Conference

Apr 4, 2016

Baxter International Inc. to Host Webcast of Annual Meeting of Stockholders

Mar 29, 2016

Baxter International Inc. to Host First Quarter 2016 Financial Results Webcast/Conference Call for Investors

Mar 24, 2016

Baxter Completes CE Mark for Expanded Indication of HEMOPATCH, an Innovative Surgical Patch, In European Union

Mar 15, 2016

Baxter Enrolls First Patient in U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System

Feb 24, 2016

Baxter to Present at the Barclays Global Healthcare Conference

Feb 17, 2016

Baxter Issues Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Solution for Irrigation Due to Presence of Particulate Matter

Feb 16, 2016

Baxter Declares Quarterly Dividend

Feb 16, 2016

Baxter to Present at the 36th Annual Cowen and Company Healthcare Conference

Feb 3, 2016

Baxter to Present at the RBC Capital Markets 2016 Global Healthcare Conference

Feb 2, 2016

Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook

Jan 22, 2016

Baxter Initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter

Jan 20, 2016

Baxter to Present at the Leerink Partners 5th Annual Global Healthcare Conference

Jan 19, 2016

Massachusetts General Hospital In Boston Receives Prestigious Foster G. Mcgaw Prize For Excellence In Community Service

Jan 6, 2016

Baxter International Fourth Quarter 2015 Financial Results Conference Call

Dec 21, 2015

Baxter to Present at the 36th Annual JP Morgan Healthcare Conference

Dec 18, 2015

Baxter Initiates Voluntary Recall of Two Lots of IV Solutions Due to Potential Presence of Particulate Matter

Nov 10, 2015

Baxter Declares Quarterly Dividend

Nov 4, 2015

Baxter Recognized as a Sustainability Leader, Develops Future Leaders and Launches New Environmental Initiatives

Nov 4, 2015

Baxter to Present at the Stifel 2015 Healthcare Conference

Oct 30, 2015

Notice of Pending Proceeding Regarding Baxter's Ongoing Efforts to Declassify Its Board and Shareholders' Related Right to Intervene

Oct 28, 2015

Baxter Names José Almeida Chairman and CEO

Oct 27, 2015

Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance

Oct 22, 2015

Baxter to Present at the Credit Suisse Healthcare Conference

Oct 21, 2015

Baxter Appoints Michael F. Mahoney to Its Board

Oct 13, 2015

Baxter Announces U.S. FDA Clearance For AMIA Automated Peritoneal Dialysis System With SHARESOURCE Connectivity Platform

Oct 1, 2015

Baxter International Third Quarter 2015 Financial Results Conference Call

Sep 30, 2015

Baxter Appoints Munib Islam to Board; Announces Agreement with Third Point

Sep 16, 2015

The Honor Society of Nursing, Sigma Theta Tau International Names Dr. Jacquelyn Campbell as its 2015 Episteme Award Recipient

Sep 3, 2015

Baxter to Present at the Morgan Stanley Global Healthcare Conference

Aug 14, 2015

Baxter and Water Street Announce FDA Approval of Cefazolin 2 Gram Premix

Aug 5, 2015

Baxter Comments on Schedule 13D Filing by Third Point

Jul 30, 2015

Baxter Initiates Voluntary Nationwide Recall of One Lot of IV Solution Due to the Potential for Leaking Containers, Particulate Matter and Missing Port Protectors

Jul 29, 2015

Baxter Declares Quarterly Dividend

Jul 29, 2015

Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance

Jul 17, 2015

Baxter initiates voluntary recall of two lots of IV solutions due to the potential presence of particulate matter

Jul 8, 2015

Baxter International Second Quarter 2015 Financial Results Conference Call

Jul 2, 2015

Baxter Announces Early Results of Debt Tender Offers

Jul 1, 2015

Baxter Announces Pricing of Debt Tender Offers

Jun 24, 2015

Baxalta Reports Continued Progress on Phase 1/2 Clinical Trial of BAX335, Investigational Gene Therapy Treatment for Hemophilia B

Jun 19, 2015

Baxalta Demonstrates Commitment to Innovation in Hemophilia and Blood Disorders at ISTH 2015 Congress

Jun 19, 2015

Baxalta Announces Pricing of $5 Billion Private Placement Notes Offering

Jun 18, 2015

Baxter Announces Debt Tender Offers

Jun 10, 2015

Baxter's Commitment to Innovative Programs and Advancing its Sustainability Priorities Featured in Sixteenth Report

Jun 9, 2015

Baxter Announces Effectiveness of Baxalta Form 10 Registration Statement

Jun 5, 2015

Baxter's Board of Directors Approves Separation of Baxalta and Declares Special Dividend of Baxalta Stock

Jun 1, 2015

Baxter Initiates Voluntary Recall of Select Product Codes of Peripheral Vascular Patch

Jun 1, 2015

Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, A Company Structured to Accelerate Therapeutic Innovation

May 29, 2015

Baxter Presents Data Demonstrating Remote Technology May Help Reduce Barriers to Home Therapy

May 28, 2015

Baxter and Baxalta Executives to Present at the Goldman Sachs 36th Annual Global Healthcare Conference

May 18, 2015

Baxter and Baxalta Highlight Business Strategies at Investor Conference

May 15, 2015

Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market

May 14, 2015

Baxter BioScience to Present New Data at ASCO from Expanding Oncology Pipeline Designed to Address Unmet Needs in Challenging Cancers

May 13, 2015

Economists Anthony Culyer and Alan Maynard Named Co-Recipients of the 2015 William B. Graham Prize For Health Services Research

May 12, 2015

Baxter BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspar® ;Portfolio for Leukemia

May 11, 2015

Baxter to Host May 2015 Investor Conferences

May 5, 2015

Baxter Declares Quarterly Dividend

May 4, 2015

Baxter BioScience and Merrimack Pharmaceuticals Announce Filing for European Approval of MM-398, an Investigational Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer

May 1, 2015

Baxter to Host May 2015 Investor Conferences

Apr 23, 2015

Baxter Reports First Quarter Financial Results That Exceed Guidance

Apr 21, 2015

Baxter to Webcast Annual Meeting of Shareholders

Apr 21, 2015

Baxter Supports IPOPI Initiative to Improve Global Care of Primary Immunodeficiencies During 5th Annual World PI Week

Apr 17, 2015

On World Hemophilia Day, Baxter is Proud to be Part of the Worldwide Hemophilia Family of Support

Apr 17, 2015

Full Data on Baxter's Investigational Recombinant Treatment BAX 111 Supports Potential Role to Treat Von Willebrand Disease

Apr 16, 2015

Baxter Submits Application to Japan's MHLW for Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A

Apr 9, 2015

Baxter Initiates Voluntary Recall of Select Lots of IV Solutions due to the Potential Presense of Particulate Matter

Apr 7, 2015

Baxter International First Quarter 2015 Financial Results Conference Call

Apr 2, 2015

Baxter and Laboratoire Aguettant Announce Global Collaboration for Parenteral Nutrition Trace Elements

Apr 1, 2015

Baxter Completes CE Mark Approval for HOMECHOICE CLARIA Automated Peritoneal Dialysis System with SHARESOURCE

Mar 30, 2015

Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving

Mar 13, 2015

Baxter BioScience Announces Positive Phase III Results for BAX 817, Investigational Recombinant Treatment for Hemophilia A and B Patients with Inhibitors

Mar 4, 2015

Baxter's BioScience Business Acquires Biopharmaceutical Company SuppreMol

Feb 23, 2015

Baxter Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters

Feb 19, 2015

Baxter to Present at Barclay's Global Healthcare Conference

Feb 17, 2015

Baxter Declares Quarterly Dividend

Feb 12, 2015

Baxter Provides Progress Update on Gene Therapy Program, Including Phase I/II Clinical Trial of BAX 335, Investigational Gene Therapy for Hemophilia B

Feb 11, 2015

Baxter Submits Application to Japan's MHLW for Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A

Feb 10, 2015

Baxter to Present at Cowen & Company's 35th Annual Health Care Conference

Jan 29, 2015

Baxter's Fourth Quarter Financial Results Exceed Expectations

Jan 29, 2015

Baxter's Fourth Quarter Financial Results Exceed Expectations

Jan 20, 2015

Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy

Jan 15, 2015

Palmetto Health in Columbia, South Carolina, Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

Dec 22, 2014

Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease

Dec 18, 2014

Baxter to Present at 33rd Annual J.P. Morgan Healthcare Conference

Dec 17, 2014

Baxter International Fourth Quarter 2014 Financial Results Conference Call

Dec 11, 2014

Baxter Voluntarily Initiates U.S. Recall of Two Lots of Sodium Chloride Injection, USP Due to the Presence of Particulate Matter

Dec 10, 2014

Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics

Dec 10, 2014

Baxter Announces Filing of Form 10 Registration Statement in Connection with Planned Spin Off of Biopharmaceuticals Business

Dec 9, 2014

Baxter's Culture of Community Engagement and Inclusion Recognized By Leading Organizations

Dec 1, 2014

Baxter Submits Application for U.S. FDA Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A

Nov 20, 2014

Baxter Initiates Voluntary Recall of One Lot of Highly Concentrated Potassium Chloride Injection in the U.S. Due to Mislabeled Overpouch

Nov 13, 2014

Baxter U.S. - Baxter to Present at the 26th Annual Piper Jaffray Healthcare Conference

Nov 11, 2014

Baxter Declares Quarterly Dividend

Nov 5, 2014

Baxter U.S. - Baxter to Present at the Stifel 2014 Healthcare Conference

Oct 30, 2014

Baxter's Investigational 20% Subcutaneous Immunoglobulin Treatment Meets Efficacy and Tolerability Endpoints in Phase 2/3 Study

Oct 24, 2014

FDA Approves Baxter's OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence], for Acquired Hemophilia A

Oct 22, 2014

Baxter Initiates Voluntary Recall of Two Lots of INTRAVIA Containers in the U.S. and Canada

Oct 22, 2014

Baxter U.S. - Baxter to Present at the 2014 Credit Suisse Healthcare Conference

Oct 17, 2014

Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency

Oct 16, 2014

Baxter's Third Quarter Financial Results Exceed Guidance

Oct 9, 2014

Baxter International Third Quarter 2014 Financial Results Conference Call

Oct 8, 2014

Baxter's Culture of Community Engagement and Inclusion Recognized By Leading Organizations

Sep 29, 2014

Baxter to Form New Global Innovation and R&D Center Near Boston for Its BioPharmaceuticals Business

Sep 25, 2014

Baxter International Third Quarter 2014 Financial Results Conference Call

Sep 24, 2014

Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398

Sep 16, 2014

Baxter Initiates U.S. Voluntary Recall of One Lot of Potassium Chloride Injection Due to Shipping Carton Mislabeling

Sep 15, 2014

FDA Approves Baxter's RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B

Sep 12, 2014

FDA Approves Baxter's HYQVIA for Treatment of Adults with Primary Immunodeficiency

Sep 10, 2014

Baxter Announces Baxalta as the Name of the New Global Biopharmaceutical Company

Aug 21, 2014

Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients

Aug 19, 2014

Baxter Announces Hemodialysis Dialyzer Expansion in Opelika, Alabama

Aug 18, 2014

Baxter to Present at Morgan Stanley Global Healthcare Conference

Aug 13, 2014

Baxter Voluntarily Initiates U.S. Recall of Two Lots of Peritoneal Dialysis Solution Due to Presence of Particulate Matter

Aug 7, 2014

Baxter Opens its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite

Aug 4, 2014

FDA Approves Baxter's FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container

Jul 31, 2014

FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter's HyQvia for Primary Immunodeficiency

Jul 30, 2014

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

Jul 22, 2014

Baxter Declares Quarterly Dividend

Jul 17, 2014

Baxter Exceeds Expectations in Second Quarter with Strong Growth Across Global Franchises

Jul 14, 2014

Baxter Initiates Voluntary Worldwide Recall of Four Lots of IV Solutions Due to the Presence of Particulate Matter

Jul 10, 2014

Baxter Appoints John Orloff, M.D., Vice President of BioScience R&D

Jul 9, 2014

Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment

Jul 7, 2014

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc.

Jun 26, 2014

Baxter International Second Quarter 2014 Financial Results Conference Call

Jun 25, 2014

Baxter Recognized for Commitment to Women's Healthcare Careers

Jun 24, 2014

Baxter Initiates Voluntary Recall of One Lot of 0.9% Sodium Chloride Injection, USP Intravenous (IV) Solution

Jun 3, 2014

Baxter Presents Efficacy and Safety Data on VIVIA Haemodialysis System at ERA-EDTA Congress

May 28, 2014

Baxter to Present at the Goldman Sachs 35th Annual Global Healthcare Conference

May 28, 2014

Baxter Builds on Global Leadership in Hemophilia A

May 21, 2014

Baxter Provides U.S. Regulatory Update on HyQvia, its Investigational Subcutaneous Treatment for Primary Immunodeficiency

May 13, 2014

Economist Stuart H. Altman, Ph.D., Named 2014 Recipient Of The William B. Graham Prize For Health Services Research

May 12, 2014

Baxter Highlights Commitment to Innovation and Focus on Improving Patient Outcomes at WFH World Congress

May 8, 2014

Baxter Receives 510(k) Clearance for Next-Generation SIGMA Spectrum Infusion Pump with Master Drug Library

May 5, 2014

Baxter Raises Quarterly Dividend Six Percent

Apr 29, 2014

Baxter to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

Apr 24, 2014

Baxter to Present at the Deutsche Bank 39th Annual Health Care Conference

Apr 23, 2014

Baxter Announces FDA Approval of ADVATE (Antihemophilic Factor [Recombinant]) with BAXJECT III Reconstitution System

Apr 22, 2014

Baxter Recognizes World PI Week, April 22-29, 2014

Apr 21, 2014

Baxter to Webcast Annual Meeting of Shareholders

Apr 16, 2014

On World Hemophilia Day, Baxter Envisions Future of Hemophilia Care

Apr 16, 2014

Baxter Provides U.S. Regulatory Update on HyQvia, its Investigational Subcutaneous Treatment for Primary Immunodeficiency

Apr 15, 2014

Baxter Meets Primary Efficacy Endpoint in Phase III Trial of BAX 111, Investigational Stand-Alone Recombinant Treatment for Von Willebrand Disease

Apr 10, 2014

Baxter Addresses Community Needs Through Charitable Giving and Educational Partnerships

Apr 3, 2014

Baxter International First Quarter 2014 Financial Results Conference Call

Apr 2, 2014

Baxter to Acquire Chatham Therapeutics

Mar 27, 2014

Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies

Mar 5, 2014

Baxter Initiates U.S. Voluntary Recall of One Lot of Peritoneal Dialysis Solution Due to Container-Closure Non-Integrity

Feb 27, 2014

Baxter Presents Data at EAHAD from Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment Experience with ADVATE

Feb 27, 2014

Baxter to Present at Barclay's Global Healthcare Conference

Feb 18, 2014

Baxter Declares Quarterly Dividend

Feb 13, 2014

Baxter to Present at Cowen & Company's 34th Annual Health Care Conference

Feb 10, 2014

Baxter to Present at Upcoming Global Healthcare Conferences

Jan 30, 2014

Baxter Announces Restructured Agreement with Xenetic BioSciences, Further Bolstering Its Broad Bleeding Disorder Pipeline

Jan 16, 2014

Crozer-Keystone Health System in Delaware County, PA. Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

Jan 6, 2014

Baxter to Present at 32nd Annual J.P. Morgan Healthcare Conference

Jan 6, 2014

Baxter International Fourth Quarter 2013 Financial Results Conference Call

Jan 3, 2014

Baxter Initiates Nationwide Voluntary Recall of Select Lots of Premix Parenteral Nutrition

Dec 23, 2013

Baxter Initiates Worldwide Voluntary Recall of Select Lots of 5% Dextrose Injection, USP and 0.9% Sodium Chloride Injection, USP Intravenous (IV) Solutions

Dec 20, 2013

Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe

Dec 19, 2013

Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment of Hemophilia A&B Patients with Inhibitors

Dec 10, 2013

Baxter Submits Application for FDA Approval OBI-1 for Patients with Acquired Hemophilia A

Dec 9, 2013

Baxter Files for Pediatric Indication of RIXUBIS (Coagulation Factor IX (Recombinant)] Treatment for Hemophilia B in the United States

Dec 2, 2013

Baxter Submits Amended BLA to U.S. FDA for HyQvia for Primary Immunodeficiency

Nov 27, 2013

Baxter Initiates Nationwide Voluntary Recall of One Lot of Nitroglycerin in 5% Dextrose Injection

Nov 15, 2013

Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib

Nov 14, 2013

Baxter to Present at the 25th Annual Piper Jaffray Healthcare Conference

Nov 13, 2013

Baxter Completes Enrollment in Phase III Clinical Trial of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A

Nov 12, 2013

Baxter Declares Quarterly Dividend

Oct 31, 2013

Baxter Submits Application for European Approval of RIXUBIS, Recombinant Factor IX (Nonacog Gamma) for Hemophilia B

Oct 29, 2013

Baxter to Present at the 2013 Credit Suisse Healthcare Conference

Oct 23, 2013

Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union

Oct 21, 2013

Baxter Promotes Wellness, Inclusion and Diversity Among its Employees, is Recognized for Ongoing Sustainability Efforts

Oct 17, 2013

Baxter Meets Expectations With Solid Financial Results for the Third Quarter 2013

Oct 15, 2013

Baxter Meets its Renewable Power Goal Early as Detailed in 2012 Sustainability Report

Oct 2, 2013

Baxter International Third Quarter 2013 Financial Results Conference Call

Sep 19, 2013

Baxter Initiates Voluntary Recall of Two Lots of Dual Luer Lock Caps

Sep 9, 2013

Baxter Appoints Todd Young As Treasurer and Corporate Officer

Sep 6, 2013

Baxter Completes Acquisition of Gambro AB and Enhances Global Leadership in Renal Therapies

Sep 3, 2013

Baxter and Coherus Biosciences Announce Collaboration to Develop and Commercialize Biosimilars

Aug 22, 2013

Baxter to Present at Morgan Stanley Global Healthcare Conference

Aug 8, 2013

The Honor Society of Nursing, Sigma Theta Tau International Names Dr. Betty Ferrell Recipient of Prestigious Episteme Award

Jul 31, 2013

Baxter and JW Holdings Announce Exclusive Global Development and Commercialization Collaboration for Omega 3 Parenteral Nutrition Products

Jul 23, 2013

Baxter Declares Quarterly Dividend

Jul 22, 2013

European Medicines Agency Approves SmPC Change to Baxter's ADVATE to Include Information on PK-Guided Dosing Study

Jul 18, 2013

Baxter Reports Solid Second Quarter Financial Results

Jul 16, 2013

Baxter Presents Additional Data from Phase III Study of Immunoglobulin for Alzheimer's Disease at AAIC

Jul 8, 2013

Baxter International Second Quarter 2013 Financial Results Conference Call

Jul 5, 2013

Baxter Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A

Jul 2, 2013

Baxter Reports Results of ADVATE Real-World Experience from Worldwide Post-Marketing Database of Hemophilia A Patients

Jun 27, 2013

FDA Approves Baxter's RIXUBIS as First Recombinant Factor IX Treatment for Routine Prophylaxis of Hemophilia B

Jun 26, 2013

Baxter Meets its Renewable Power Goal Early as Detailed in 2012 Sustainability Report

May 25, 2013

Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

May 23, 2013

Baxter to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

May 21, 2013

Baxter Receives Marketing Authorization for HyQvia in European Union

May 9, 2013

Health Statistics Pioneer Dorothy P. Rice, Sc.D., Named 2013 Recipient of the William B. Graham Prize for Health Services Research

May 7, 2013

Baxter Raises Dividend Nine Percent

May 7, 2013

Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease

Apr 25, 2013

Baxter to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Apr 24, 2013

Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research

Apr 23, 2013

Baxter to Webcast Annual Meeting of Shareholders

Apr 18, 2013

Baxter Achieves Its First Quarter Expectations and Confirms 2013 Full-Year Guidance

Apr 16, 2013

Baxter Marks World Hemophilia Day By Reinforcing Commitment to Addressing Disparities in Care and Sharing New Vision for the Future

Apr 2, 2013

Baxter Taps New Technologies, Forms Collaborations to Improve Environmental Sustainability and Access to Healthcare

Mar 28, 2013

Baxter and Chatham Announce Dosing of First Patient in Phase I/II Clinical Trial of BAX 335, an Investigational Hemophilia B Gene Therapy Treatment

Mar 27, 2013

Baxter International First Quarter 2013 Financial Results Conference Call

Mar 22, 2013

Baxter and Halozyme Announce Positive Opinion for HyQvia for Treatment of Primary and Secondary Immunodeficiencies

Feb 27, 2013

Baxter to Present at Raymond James 34th Annual Institutional Investors Conference

Feb 26, 2013

Baxter Submits Application for FDA Approval of FEIBA NF for Prophylactic Use in Hemophilia A and B Patients with Inhibitors

Feb 19, 2013

Baxter Declares Quarterly Dividend

Feb 7, 2013

Baxter to Present at Upcoming Global Healthcare Conferences

Jan 24, 2013

Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets

Jan 23, 2013

St. Joseph's/Candler Health System in Savannah, Ga. Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

Jan 23, 2013

Baxter Reports Record Sales, Earnings and Cash Flow for Full-Year 2012

Jan 16, 2013

Crozer-Keystone Health System in Delaware County, PA. Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

Jan 14, 2013

Baxter International Fourth Quarter 2012 Financial Results Conference Call

Jan 8, 2013

Baxter Announces Phase III Data Evaluating Prophylaxis Treatment of FEIBA NF for Hemophilia Patients with Inhibitors

Jan 7, 2013

Baxter to Initiate Late-Stage Clinical Trial of BAX 855 for the Treatment of Hemophilia A

Dec 20, 2012

Baxter to Present at 31st Annual J.P. Morgan Healthcare Conference

Dec 10, 2012

Baxter Presents Phase I/III Data Evaluating Safety and Efficacy of BAX 326, An Investigational Recombinant Factor IX for Hemophilia B, Showing More Than 40 Percent of Patients Experienced No Bleeds

Dec 4, 2012

Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro

Nov 13, 2012

Baxter Declares Quarterly Dividend

Nov 8, 2012

Baxter to Present at the 24th Annual Piper Jaffray Healthcare Conference

Nov 5, 2012

Baxter's Commitment to Incorporating Sustainable Practices into Business Recognized by Leading Organizations

Nov 1, 2012

Baxter Announces Long-Term Partnership in Brazil to Expand Access to Recombinant FVIII Hemophilia Treatment

Oct 24, 2012

Baxter to Present at Credit Suisse 21st Annual Healthcare Conference

Oct 18, 2012

Baxter Delivers Solid Financial Performance In Line with Guidance for Third Quarter 2012

Oct 9, 2012

Baxter Hosts 2012 Investor Conference

Sep 27, 2012

Baxter Appoints Two New Directors to Its Board

Sep 27, 2012

Baxter International Third Quarter 2012 Financial Results Conference Call

Sep 19, 2012

Baxter Hosting Investor Conference on October 9, 2012

Sep 19, 2012

Baxter and Onconova Announce European Licensing Agreement for Anti-Cancer Compound Rigosertib

Sep 5, 2012

Baxter Initiates Phase I Clinical Trial with Anti-MIF Antibody in Patients with Solid Tumors

Sep 4, 2012

Baxter Submits Application for FDA Approval of Recombinant Factor IX for the Treatment of Hemophilia B

Aug 22, 2012

Baxter to Present at Morgan Stanley Global Healthcare Conference

Aug 1, 2012

Baxter Confirms Receipt of Complete Response Letter on HyQ

Jul 25, 2012

Baxter Raises Dividend 34 Percent and Announces New $2 Billion Share Repurchase Program

Jul 19, 2012

Baxter Announces Collaboration with Sanquin to Expand Capacity for Plasma Therapies

Jul 19, 2012

Baxter Reports Second Quarter Financial Results In Line with Guidance

Jul 17, 2012

Baxter Announces Collaboration with Sanquin to Expand Capacity for Plasma Therapies

Jul 16, 2012

Baxter Announces FDA Approval of ADVATE 4000 IU Dosage Strength

Jun 27, 2012

Baxter's 2011 Sustainability Report Focuses on Creating Lasting Value for Stakeholders

Jun 26, 2012

Baxter International Second Quarter 2012 Financial Results Conference Call

Jun 26, 2012

Baxter's SIGMA Spectrum Infusion System Receives Best in KLAS Award for Second Consecutive Year

Jun 25, 2012

Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy

Jun 18, 2012

Baxter's SIGMA Spectrum Infusion System Receives Best in KLAS Award for Second Consecutive Year

Jun 4, 2012

Baxter Announces Collaboration with Chatham Therapeutics for Factor IX Hemophilia B Gene Therapy Treatment

May 30, 2012

Baxter to Present at William Blair & Company 32nd Annual Growth Stock Conference

May 25, 2012

Baxter's Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis

May 23, 2012

Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference

May 16, 2012

Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A

May 7, 2012

Baxter Declares Quarterly Dividend

May 2, 2012

Baxter to Present at Bank of America Merrill Lynch 2012 Healthcare Conference

May 1, 2012

Leading Health Economist Mark V. Pauly, Ph.D., Named 2012 Recipient of the William B. Graham Prize for Health Services Research

Apr 27, 2012

Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting

Apr 26, 2012

Baxter Completes Purchase of SIGMA International

Apr 24, 2012

Baxter to Present at Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference

Apr 23, 2012

Baxter to Webcast Annual Meeting of Shareholders

Apr 19, 2012

Baxter Exceeds Revenue and EPS Guidance with Solid First Quarter Financial Results

Apr 19, 2012

Baxter Announces Biologics Capacity Expansion to Support Global Growth in Plasma-derived Therapies

Apr 16, 2012

Baxter and Halozyme Provide Update on HyQ Biologics License Application

Mar 22, 2012

Baxter International First Quarter 2012 Financial Results Conference Call

Mar 21, 2012

Baxter and its Foundation Aid Local Communities through 2011 Charitable Giving

Mar 2, 2012

Baxter Receives Marketing Authorization in European Union for VEPACEL Pre-Pandemic Influenza Vaccine

Mar 2, 2012

Baxter Presents Long-Term Data on HyQ During AAAAI Annual Meeting

Feb 29, 2012

Baxter to Present at the Barclays Capital 2012 Global Healthcare Conference

Feb 28, 2012

Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition

Feb 21, 2012

Baxter Declares Quarterly Dividend

Feb 20, 2012

Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference

Feb 15, 2012

Baxter to Present at the Citi 2012 Global Healthcare Conference

Feb 14, 2012

Baxter to Present at the RBC Capital Markets Healthcare Conference

Feb 14, 2012

Baxter Completes Acquisition of Synovis

Feb 13, 2012

Baxter to Host Investor Conference on October 9, 2012

Feb 2, 2012

Baxter to Present at the Leerink Swann 2012 Global Healthcare Conference

Jan 30, 2012

Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery

Jan 26, 2012

Baxter Reports Sales and EPS for Fourth Quarter and Full-Year 2011 In Line with Guidance

Jan 24, 2012

Mt. Ascutney Hospital and Health Center in Vermont Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

Jan 23, 2012

Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID (IGIV) for the Treatment of Alzheimer's Disease

Jan 9, 2012

Baxter Appoints Jean-Luc Butel as President, International

Jan 9, 2012

Baxter Submits Application for FDA Approval of GAMMAGARD LIQUID to Treat Multifocal Motor Neuropathy, a Degenerative Neurological Disorder

Jan 5, 2012

Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A

Jan 4, 2012

Baxter International Fourth Quarter 2011 Financial Results Conference Call

Jan 4, 2012

Baxter Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital

Dec 22, 2011

FDA Approves Baxter's ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children with Hemophilia A

Dec 22, 2011

Baxter and Momenta Announce Collaboration to Develop and Commercialize Follow-on Biologics

Dec 21, 2011

Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference

Dec 16, 2011

FDA Approves Baxter's ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children with Hemophilia A

Dec 15, 2011

Baxter Responds to Patient Needs in Aftermath of Thailand Floods

Dec 13, 2011

Baxter Signs Definitive Agreement to Acquire Synovis

Nov 17, 2011

Baxter to Present at the 23rd Annual Piper Jaffray Health Care Conference

Nov 15, 2011

Baxter Raises Quarterly Dividend

Nov 10, 2011

Baxter Completes Acquisition of Baxa Corporation

Nov 7, 2011

Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American College of Allergy, Asthma & Immunology Meeting

Nov 4, 2011

Baxter Introduces NUMETA in Europe as the First-Ever Triple-Chamber IV Nutrition System for Preterm Newborns and Children

Nov 2, 2011

Statement on Prophylaxis with FEIBA - Study Results Published Today in The New England Journal of Medicine

Oct 26, 2011

Baxter to Present at the Credit Suisse 2011 Healthcare Conference

Oct 20, 2011

Baxter Reports Strong Third Quarter Financial Results and Confirms Full-Year Guidance

Oct 14, 2011

Baxter Initiates Phase III Trial of Investigational BAX 111 for the Treatment of von Willebrand Disease

Oct 6, 2011

Honor Society of Nursing Recognizes Researcher for Contributions to Evidence-Based Practice Research

Oct 3, 2011

Baxter Advances Initiative Supporting Math and Science Education

Sep 30, 2011

Baxter Submits European Marketing Authorization Application for HyQ, an Investigational IG Therapy for Primary Immunodeficiencies

Sep 30, 2011

Leading Nutrition Experts Convene First-Ever Summit to Address Parenteral Nutrition Safety

Sep 21, 2011

Baxter International Inc. Third Quarter 2011 Financial Results Conference Call

Aug 31, 2011

Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures

Aug 30, 2011

Baxter to Present at the UBS Global Life Sciences Conference

Aug 25, 2011

Baxter to Acquire Privately Held Baxa Corporation

Aug 22, 2011

Baxter to Present at Morgan Stanley Global Healthcare Conference

Jul 28, 2011

Baxter Establishes Baxter Ventures to Invest in Early-Stage Therapies

Jul 26, 2011

Baxter Declares Quarterly Dividend

Jul 26, 2011

Baxter Presents Preclinical Data at ISTH on its Investigational Compound BAX 499 for Potential Subcutaneous Hemophilia Therapy and Final Phase I Data on Recombinant Von Willebrand Factor

Jul 25, 2011

Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency

Jul 21, 2011

Baxter's Second Quarter Financial Results Exceed Guidance; Company Raises Full-Year Financial Outlook

Jul 8, 2011

Baxter and Halozyme Announce Top-Line Results of Phase III Study of HyQ in Patients with Primary Immunodeficiency

Jul 7, 2011

Phase Two Study Suggests Use of Adult Autologous Stem Cells May Improve Cardiac Function in Angina Patients

Jun 30, 2011

Baxter 2010 Sustainability Report Details Progress Toward Priorities and Goals

Jun 24, 2011

Baxter Receives Positive Opinion for IVIG Therapy in Europe for Treatment of Multifocal Motor Neuropathy

Jun 20, 2011

Baxter International Inc. Second Quarter 2011 Financial Results Conference Call

Jun 13, 2011

Baxter Introduces First Ready-to-Use IV Amiodarone

Jun 8, 2011

Baxter to Present at Goldman Sachs 32nd Annual Global Healthcare Conference

May 26, 2011

Baxter to Present at William Blair & Company 31st Annual Growth Stock Conference

May 18, 2011

Baxter to Present at Goldman Sachs 32nd Annual Global Healthcare Conference

May 4, 2011

Baxter to Present at Deutsche Bank Securities Inc. 36th Annual Health Care Conference

May 2, 2011

Baxter Declares Quarterly Dividend

Apr 28, 2011

Founder of Group Health Research Institute, Edward H. Wagner, MD, MPH, Named 2011 Recipient of the William B. Graham Prize for Health Services Research

Apr 21, 2011

Baxter's First Quarter Financial Results Exceed Guidance

Apr 18, 2011

Baxter Presents Phase III Clinical Study Data Assessing the Use of ARTISS for Facelift Surgery

Apr 18, 2011

Baxter Announces the Acquisition of Prism Pharmaceuticals

Apr 13, 2011

Baxter Supports New Advocacy in Action Initiative to Assist People Living with Bleeding Disorders to Achieve and Maintain Access to Care

Apr 11, 2011

Baxter Presents Phase III Clinical Study Data Assessing the Use of ARTISS for Facelift Surgery

Mar 29, 2011

Baxter and its Foundation Expand Access to Healthcare and Education Through 2010 Charitable Contributions

Mar 24, 2011

Baxter International Inc. First Quarter 2011 Financial Results Conference Call

Mar 23, 2011

Baxter Appoints James Saccaro as Treasurer and Corporate Officer

Mar 17, 2011

Baxter to Present at Barclay's Capital 2011 Global Healthcare Conference

Mar 2, 2011

Baxter's PREFLUCEL Seasonal Influenza Vaccine Receives European Repeat Mutual Recognition Approval

Feb 23, 2011

Baxter to Present at the 2011 RBC Capital Markets' Healthcare Conference

Feb 15, 2011

Phase III Data Published in The Lancet Show Baxter's PREFLUCEL Protective Against Seasonal Influenza

Feb 15, 2011

Baxter Appoints Two Corporate Officers

Feb 15, 2011

Baxter Declares Quarterly Dividend

Jan 31, 2011

Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition

Jan 13, 2011

Allegiance Health in Michigan Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service